_256_384.jpg){kind=logo}
News | July 04, 2022
Microsize launched as Independent pharma services company
Meets the growing need for US-based API solubility and bioavailability enhancement services
Meets the growing need for US-based API solubility and bioavailability enhancement services
Prior to this, Maria held multiple roles at Novartis including Head of Global Manufacturing Functions, and Global Head of Manufacturing, Science & Technology
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport
Brings 25 years of global operations and supply chain experience to Piramal
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Subscribe To Our Newsletter & Stay Updated
